NCT02851953View on ClinicalTrials.gov

Effectiveness and Safety Evaluation of Aqueduct -100 Device

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
Cervix Uteri Dilation
Interventions
DEVICE

Aqueduct-100

Trial Locations (1)

16132

Irccs Azienda Ospedaliera Universitaria San Martino Ist, Genova

Sponsors
All Listed Sponsors
collaborator

Sintesi Research Srl

INDUSTRY

lead

Aqueduct Medical Ltd

INDUSTRY

NCT02851953 - Effectiveness and Safety Evaluation of Aqueduct -100 Device | Biotech Hunter | Biotech Hunter